| Factor Information | |
|---|---|
| Data ID | 691 |
| Factor | cryoprecipitate tansfusion |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | neonate and infant with CHD undergoing cardiac surgery |
| p Value | <0.01 |
| OR | 1.076 |
| Conclusion | Transfusion of cryoprecipitate was associated with thrombosis. |
| Risk Factor | no influencing factor |
| CHD Type | |
|---|---|
| ID | 138 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 28981194 |
| Year | 2017 |
| Title | Elevated preoperative von Willebrand Factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | neonate and infant | |
| Source | data | |
| Region | USA,MA | |
| Method | univatiate and multivariate analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | palliation or definitive repair of CHD | |
| Group | thrombosis(Treatment) | no thrombosis(Control) |
| Number | 12 | 121 |
| Age | 2(79)days | 59(124)days |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 26.7 mL/kg | 2.0 mL/kg |
